About Renalytix Tech
Renalytix Tech is a company based in New York (United States) founded in 2018 by Girish Nadkarni.. Renalytix Tech offers products and services including KidneyIntelX.dkd. Renalytix Tech operates in a competitive market with competitors including Aiosyn, PaxeraHealth, Bio-AI Health, Visla Labs and Carenostics, among others.
- Headquarter New York, United States
- Founders Girish Nadkarni
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Renalytix Plc
-
Annual Revenue
$2.28 M (USD)-35.73as on Jun 30, 2024
-
Net Profit
$-33.3 M (USD)29.91as on Jun 30, 2024
-
EBITDA
$-28.45 M (USD)34.52as on Jun 30, 2024
-
Latest Funding Round
$20.3 M (USD), Post-IPO
Feb 08, 2023
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Renalytix Tech
Renalytix Tech is a publicly listed company on the LSE with ticker symbol RENX in UK, operating in the Technology services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Renalytix Tech
Renalytix Tech offers a comprehensive portfolio of products and services, including KidneyIntelX.dkd. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Predicts risk of kidney function decline in diabetic patients over five years.
Unlock access to complete
Unlock access to complete
Funding Insights of Renalytix Tech
- Total Funding Total Funding
- Total Rounds 1
- Last Round Post-IPO — $20.3M
-
First Round
First Round
(08 Feb 2023)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Post-IPO - Renalytix Tech | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Renalytix Tech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Renalytix Tech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Renalytix Tech Comparisons
Competitors of Renalytix Tech
Renalytix Tech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aiosyn, PaxeraHealth, Bio-AI Health, Visla Labs and Carenostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based tools are developed for clinical disease diagnosis by providers.
|
|
| domain | founded_year | HQ Location |
AI-based medical image management solutions are offered for organizations.
|
|
| domain | founded_year | HQ Location |
AI-based disease diagnosis is provided for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Functions as an AI-based tool for disease diagnosis in healthcare.
|
|
| domain | founded_year | HQ Location |
AI-based tools are employed for disease diagnosis.
|
|
| domain | founded_year | HQ Location |
Cloud and AI-based diagnostics are provided for health providers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Renalytix Tech
Frequently Asked Questions about Renalytix Tech
When was Renalytix Tech founded?
Renalytix Tech was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Where is Renalytix Tech located?
Renalytix Tech is headquartered in New York, United States. It is registered at New York, New York, United States.
What is the annual revenue of Renalytix Tech?
Annual revenue of Renalytix Tech is $2.28M as on Jun 30, 2024.
What does Renalytix Tech do?
Renalytix Tech was founded in 2018 in New York, United States, as a provider in the healthcare sector focused on AI-driven solutions for kidney disease. Software such as KidneyIntelX is utilized by clinics to analyze medical data, monitor treatment progress, assess risks, and generate AI-based scores for disease progression. Operations emphasize diagnostic support for professionals, with features tailored to kidney measurements and overall patient risk evaluation.
Who are the top competitors of Renalytix Tech?
Renalytix Tech's top competitors include Aiosyn, Bio-AI Health and lifespin.
What products or services does Renalytix Tech offer?
Renalytix Tech offers KidneyIntelX.dkd.
Is Renalytix Tech publicly traded?
Yes, Renalytix Tech is publicly traded on LSE under the ticker symbol RENX.
What is Renalytix Tech's ticker symbol?
The ticker symbol of Renalytix Tech is RENX on LSE.